Acurx Pharmaceuticals Inc... (ACXP)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.73
-0.05 (-6.05%)
At close: Jan 29, 2025, 3:59 PM
0.73
0.68%
After-hours Jan 29, 2025, 05:25 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a |
Operating Income | -14.58M | -12.09M | -12.88M | -4.60M | -5.93M |
Interest Income | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -14.58M | -12.09M | -12.75M | -4.60M | -5.93M |
Net Income | -14.58M | -12.09M | -12.68M | -4.60M | -5.93M |
Selling & General & Admin | 8.53M | 7.34M | 10.78M | 2.40M | 2.42M |
Research & Development | 6.04M | 4.75M | 2.03M | 2.20M | 3.51M |
Other Expenses | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 14.58M | 12.09M | 12.81M | 4.60M | 5.93M |
Interest Expense | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 14.58M | 12.09M | 12.81M | 4.60M | 5.93M |
Income Tax | n/a | -1.22K | -66.50K | -4.60K | -5.93K |
Shares Outstanding (Basic) | 12.67M | 10.82M | 10.22M | 9.92M | 9.92M |
Shares Outstanding (Diluted) | 12.67M | 10.82M | 10.22M | 9.92M | 9.92M |
EPS (Basic) | -1.15 | -1.12 | -1.24 | -0.46 | -0.6 |
EPS (Diluted) | -1.15 | -1.12 | -1.24 | -0.46 | -0.6 |
EBITDA | n/a | -12.09M | n/a | -4.60M | -5.93M |
Depreciation & Amortization | 14.58M | 12.09M | 12.81M | 4.60M | 5.93M |